EC approves Novo Holding’s $16.5bn acquisition of Catalent
EC said the transaction, expected to be closed by the end of this year, would not raise competition concerns in the European Economic Area (EEA), including the 27 EU countries,...
AstraZeneca secures FDA priority review for Imfinzi in MIBC
Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma
GSK, Zhifei expand shingles vaccine partnership in China
Lilly to invest $3bn to expand its recently acquired facility in Wisconsin, US
Teva to divest Teva Takeda Pharma JV in Japan to JKI
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry